China OKs Hemophilia B Trial Testing BBM-H901 Gene Therapy

China OKs Hemophilia B Trial Testing BBM-H901 Gene Therapy

Hemophilia News Today

Image

Please enable the javascript to submit this form

Supported by educational grants from Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc.

Essential SSL